Submit When the Science Is Done: White Paper

Submit when the science is done

After Last Patient Last Visit, the science is done, yet submissions take months and regulatory review months more. This white paper examines why, and how a study kept continuously validated against its own code can be submitted within days of LPLV.

Learn how the Verisian Harness makes agentic AI trustworthy in clinical trials, how experts stay in control at every quality gate, and what changes for planning, validation, submission documents, study pooling and regulatory review.

Enter your details for instant access to the white paper. The information you provide will be used in accordance with the terms of our Privacy Policy.

Latest from Verisian

Perspectives

AI and the Economics of Time: Part 2

In part two of Carol Collins' Economics of Time Series, the focus shift to the economics of capacity; some of the most valuable AI initiatives are not those that simply automate work, but ones that simultaneously reduce delay and unlock capacity.

Carol Collins

October 21, 2026

Use Case

Verisian AI Agents Automate ADaM Programming and Validation

We tested Verisian’s AI agents on the R Consortium’s Pilot 3, a public ADaM submission package reviewed by the FDA. Given only the SAP, SDTM data and specifications, the agents derived and validated all five ADaM datasets in a single working day, with no human writing code.

Henning Kuich

October 20, 2026

Perspectives

Upskilling Teams in the AI Era

"Who checks the AI?" is the question that decides whether this industry's AI era is a success or a cautionary tale. In this article, Andy York, former VP of Statistical Programming at Novo Nordisk and Verisian advisor, discusses the coming role shift and the skills that will matter.

Andrew York

October 16, 2026

See all updates from Verisian

Thank You

Thank you